Gastroenterology Research and Practice / 2013 / Article / Fig 4

Research Article

Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo

Figure 4

Percentage of apoptotic cells included both early- and late-stage apoptosis (AV+/PI− and AV+/PI+) was detected by FCM. The apoptosis rates of NET-1shRNA, sorafenib, combination, and untreated group were 24 ± 0.72%, 17.64 ± 0.46%, 51.34 ± 1.25%, and 6.3 ± 0.03%, respectively.
685150.fig.004a
(a)
685150.fig.004b
(b)
685150.fig.004c
(c)
685150.fig.004d
(d)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.